Rebecca Hyde Included in Distinguished Registry
Rebecca Hyde has a demonstrated track record in building, managing and growing successful businesses which service the pharmaceutical and biotechnology industries

SOMERSET, NJ, May 6, 2011 /24-7PressRelease/ -- Rebecca Hyde, former Partner of Strategyx and Executive Vice President - Global Communications for inVentiv Advance Insights, has been recognized by Cambridge Who's Who for demonstrating dedication, leadership and excellence in the development and implementation of access and reimbursement strategies for complex biologics and pharmaceutical products.

Ms. Hyde is a veteran of the pharmaceutical industry with over 25 years of professional experience. Equipped with a bachelor's degree in chemical engineering, she began her career in specialty chemical manufacturing then rapidly progressed to the development and marketing of pharmaceutical products. Upon leaving Hoechst Marion Roussel (currently Sanofi Aventis), she founded Strategyx, a management consultancy which specialized in the development of access and reimbursement strategies in the U.S. payer market. This consultancy was acquired by inventive Health in 2007. Ms. Hyde continued the development of commercialization strategy capabilities within the inventive Advance Insights organization where she was responsible for the Global Commercialization consulting group.

Finding success through her desire and ability to tackle new challenges, Ms. Hyde looks forward to continuing to assist her clients in appropriately positioning their pharmaceutical products for commercial success in the patient, physician and payer sectors.

Press Release Contact Information:

Ellen Campbell
Cambridge Who's Who
Public Relations
498 RXR Plaza, West Tower
Uniondale, NY
USA 11556
Voice: 516-535-1515 x4266
Website: Visit Our Website